PIK3CA and neoplasm: The aim of this study was to determine the in vitro and in vivo activity of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037, alone and in combination, in colorectal carcinoma cell lines and tumour xenograft-bearing mice.